Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

1(14%)

Results Posted

0%(0 trials)

Terminated

1(14%)

Phase Distribution

Ph not_applicable

71%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

N/ANon-phased studies

5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Terminated(1)

Detailed Status

Completed5

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed571%

recruiting114%

terminated114%

Recent Activity

1 active trials

Showing 5 of 7

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT03455582Not Applicable

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years

Completed

NCT03692975Not Applicable

MRI Hippocampal Microstructure and Episodic Memory in Early Multiple Sclerosis

Terminated

NCT04043052Not Applicable

Mobile Technologies and Post-stroke Depression

Completed

NCT03768648Not Applicable

Cognition and MRI Markers in MS Patients With Aubagio® Treatment

Completed

NCT04422730

Evolution of Body Connection After Surgery

Completed

NCT03812913

Neuropsychological Assessment of Children and Adolescents With Turner Syndrome

Recruiting

NCT03349554Not Applicable

A Standardized Meditation Technique "Body-scan", in the Management of Anxiety in Hospitalized Parkinsonian Patients

Completed

All 7 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 7